Invest in Biotech and Information Sciences

 

Published June 07, 2001

If we invest heavily in biotechnology and information services companies (especially genomics, networked centralized computing, neurology, neural network predictive applications, and nerve regeneration) in the next 50 years, many currently living people may have an opportunity to achieve substantially improved and lengthened quality of life and indefinitely extended sentience.

It's more than a financial return, but it can still be evaluated financially. The return on these investments should be calculated as the return on the securities themselves, plus the return on your other investments over the period of time that your life and investment horizon are extended. It is possible, then, that the net return on biotech and information science investments may be substancially higher than the direct value change for those investment securities.

Labels:


E-mail this article:
Comments:
Post a Comment

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Google
Web
Blog

[Back to Top]
Copyright © Dan Von Kohorn, 1999 - 2008. All Rights Reserved.
Article content is licensed under a Creative Commons License except where noted.
Creative Commons License

Investment Commentary
Use Maxmind
This page is powered by Blogger. Isn't yours? Blogarama - The Blog Directory

 

Important Legal Information: This is a personal web site, reflecting the opinions of its author. It is not a production of my employer, and it is unaffiliated with any NASD broker/dealer. Statements on this site do not represent the views or policies of anyone other than myself. The information on this site is provided for discussion purposes only, and are not investing recommendations. Under no circumstances does this information represent a recommendation to buy or sell securities.